DCVC (Data Collective Venture Capital) is a venture capital firm that invests in early-stage and growth-stage companies applying artificial intelligence, machine learning, and other advanced computational techniques to sectors such as healthcare, climate, defense, and enterprise infrastructure. The firm was founded in 2011 by Matt Ocko and Zachary Bogue, who sought to back founders using deep tech to create defensible, data-driven businesses. DCVC is headquartered in San Francisco, California, and manages multiple funds with assets under management exceeding $3 billion as of 2024.
The firm's investment thesis centers on the idea that the convergence of cheap computing, vast datasets, and algorithmic advances creates outsized opportunities for startups that can leverage these tools to disrupt traditional industries. DCVC typically leads or co-leads funding rounds, providing not only capital but also operational support, access to a network of technical experts, and guidance on scaling complex products. Its portfolio includes notable companies such as OpenAI, Anthropic, Groq, SambaNova, and Intuitive Surgical, among others.
Investment Strategy and Focus
DCVC distinguishes itself from generalist venture firms by concentrating on what it calls 'deep tech' - startups where the core innovation is a scientific or engineering breakthrough rather than a business model tweak. The firm evaluates opportunities based on the 'data moat' concept, favoring companies that generate proprietary datasets through their operations, which can be used to train Machine learning models that improve over time. This approach is particularly relevant in fields like precision medicine, where companies like Commure and Omniscient use clinical data to build predictive tools.
The firm also emphasizes 'computational biology' and 'computational climate' as key verticals. For example, it has invested in Fermata, which uses computer vision to detect crop diseases, and in BigBear.ai, which applies analytics to supply chain and defense logistics. DCVC's partners often have technical backgrounds, including PhDs in physics, computer science, and engineering, which helps them assess the feasibility of complex technologies.
Notable Portfolio Companies
DCVC was an early investor in OpenAI, the research organization behind Generative AI systems like GPT-4, and in Anthropic, a competitor focused on AI safety. The firm also backed Groq, a startup developing custom Neural network inference chips, and SambaNova, which builds specialized hardware and software for Deep learning workloads. In healthcare, DCVC invested in Intuitive Surgical, the maker of the da Vinci surgical robot, and in Commure, a platform for healthcare data interoperability.
Other portfolio companies include Waymo, the self-driving car unit of Alphabet, and Tesla, though DCVC's stake in the latter was indirect through early funding rounds. The firm has also supported Sanctuary AI and Figure AI, both developing humanoid robots, and AI21 Labs, which creates large language models for enterprise use. These investments reflect a pattern of backing companies that push the boundaries of what is possible with Artificial intelligence in physical and digital domains.
Impact on the AI Ecosystem
DCVC has played a significant role in the growth of the AI startup ecosystem, particularly in the San Francisco Bay Area. By providing early capital to foundational AI companies, the firm has helped accelerate the development of Large language model technology and its commercial applications. Its investments in hardware startups like Groq and SambaNova have also contributed to the diversification of the AI chip market, challenging the dominance of NVIDIA and AMD in data center training and inference.
The firm is known for its 'full-stack' approach, meaning it supports companies from the semiconductor level up to application software. This strategy has led to investments in AWS Trainium (Amazon's custom AI chip) and in Graphcore, a UK-based chip designer, though the latter faced financial difficulties and was acquired in 2023. DCVC's willingness to fund high-risk, capital-intensive ventures has made it a preferred partner for scientists and engineers looking to commercialize research from institutions like MIT CSAIL and Stanford AI Lab.
Leadership and Team
DCVC is led by co-founders Matt Ocko and Zachary Bogue. Ocko, who previously worked as a technology executive and investor, focuses on deal sourcing and portfolio strategy. Bogue, a former policy advisor and entrepreneur, leads the firm's efforts in defense and national security investments. The team includes partners with experience at Google DeepMind, Xerox PARC, and Nokia Bell Labs, providing a deep bench of technical expertise. The firm also employs a team of data scientists and engineers who conduct due diligence on potential investments, often building prototypes to test the viability of a startup's technology.
Challenges and Criticisms
Like many venture firms, DCVC has faced challenges related to the cyclical nature of tech funding. The downturn in tech valuations in 2022-2023 led to markdowns in some portfolio companies, particularly in the autonomous vehicle and robotics sectors. Critics have also noted that the firm's focus on 'deep tech' can lead to long investment horizons, with some companies taking over a decade to reach profitability. Additionally, DCVC's investments in defense-related startups have drawn scrutiny from activists concerned about the militarization of AI, though the firm argues that such technologies are essential for national security.
Despite these challenges, DCVC remains a prominent player in the venture capital landscape, with a track record of backing transformative companies. As of 2025, the firm continues to raise new funds and expand its focus to include areas like quantum computing and synthetic biology, aligning with its mission to support computational innovation.